Stay updated on Herpesvirus Treatment in IPF Clinical Trial
Sign up to get notified when there's something new on the Herpesvirus Treatment in IPF Clinical Trial page.

Latest updates to the Herpesvirus Treatment in IPF Clinical Trial page
- Check5 days agoChange DetectedThe page now displays the completed clinical trial record for a pilot study of valganciclovir treatment in idiopathic pulmonary fibrosis, including study design, eligibility, outcomes, and a linked protocol. The previous error page is no longer shown.SummaryDifference53%

- Check12 days agoChange DetectedThe footer now identifies the site revision as v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check19 days agoChange DetectedA banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check26 days agoChange DetectedThe footer’s site revision indicator changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on a page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now returns a 403 Forbidden error, blocking access to the study details. Access to the NCT02871401 record is restricted, and the trial information is not visible.SummaryDifference19%

Stay in the know with updates to Herpesvirus Treatment in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Herpesvirus Treatment in IPF Clinical Trial page.